semaglutide shortage ending What's New in Obesity Treatment? The GLP-1 drug shortage is

Comparison of ELISA kits Human serum samples were analysed for both isoforms (pro-BDNF and BDNF) in three different brands and at three dilutions per assay, chosen according to: (i) the manufacturers recommendations (Table 1), (ii) the scientific literature (Supplementary Table S1), and (iii) considering one common dilution for all commercial brands tested

Ivanov AV, Alexandrin VV, Paltsyn AA, et al

10.1111/acps.12711 Acta Psychiatr

Current guidelines do not recommend combination therapy with GLP-1 RAs and DPP-4 inhibitors, and the ADA/EASD consensus report specifically recommends discontinuation of DPP-4 inhibitors when initiating GLP-1 RA therapy

Per- and polyfluoroalkyl substances (PFAS) and lipid trajectories in women 4556 years of age: the study of womens health across the Nation